$AKRX Recent News

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2014 at 11:23 AM

$AKRX Recent News

Speculators live by the sword, die by the sword
3:13 p.m. July 8, 2014
- The Trading Deck

Dow, Nasdaq nail the breakout point
10:36 a.m. June 27, 2014
- Michael Ashbaugh

From tiny Akorns grow mighty oaks?
11:03 a.m. Nov. 21, 2013
- The Trading Deck

Rail-Splitter's top small-cap bets are worth watching
12:34 p.m. Nov. 4, 2013
- Insider Monkey

Akorn to buy Hi-Tech for $640 million in cash
8:02 a.m. Aug. 27, 2013
- MarketWatch.com

Monday’s biggest gaining and declining stocks
4:20 p.m. July 23, 2012
- MarketWatch

Corrective bounce, or sustainable upturn?
10:59 a.m. June 6, 2012
- Michael Ashbaugh

Charting a bearish double top
12:11 p.m. May 15, 2012
- Michael Ashbaugh

Charting a bearish double top
11:45 a.m. May 15, 2012
- Michael Ashbaugh

Wednesday’s biggest gaining and declining stocks
6:02 p.m. March 7, 2012
- Sue Chang

Tuesday’s biggest gaining and declining stocks
5:23 p.m. March 6, 2012
- MarketWatch

Stocks to watch Tuesday: Nutrisystem, Jakks
8:00 a.m. March 6, 2012
- MarketWatch

S&P 500 scratches out three-year high
12:07 p.m. March 2, 2012
- Michael Ashbaugh

Stocks to watch Friday: LinkedIn, LeapFrog, Nuance
7:46 a.m. Feb. 10, 2012
- MarketWatch

S&P 500 vies for positive 2011 finish
12:09 p.m. Dec. 23, 2011
- Michael Ashbaugh

S&P, Nasdaq retest major support
12:51 p.m. Dec. 12, 2011
- Michael Ashbaugh

U.S. markets survive test of major support
10:57 a.m. Nov. 2, 2011
- Michael Ashbaugh

Akorn rallies on earnings, M&A deal
1:59 p.m. Aug. 2, 2011
- Val Brickates Kennedy

Drug stocks slip; Emergent rallies
1:28 p.m. May 26, 2011
- Val Brickates Kennedy

Drug stocks gain; Derma, Elan climb
3:51 p.m. May 25, 2011
- Val Brickates Kennedy

Acquisition-Hungry Akorn Sets Up Potential Buy Area

5:10 p.m. Sept. 22, 2014
- Investors Business Daily

Analysts Are Warming to These 5 Stocks

9:25 a.m. Sept. 22, 2014
- InvestorPlace.com

IBD 50: Akorn Aims For $1 Billion In Sales

5:35 p.m. Sept. 19, 2014
- Investors Business Daily

IBD 50 Stocks Setting Up, Including These 5 Medicals

5:35 p.m. Sept. 19, 2014
- Investors Business Daily

Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog

4:30 p.m. Sept. 18, 2014
- Zacks.com

Will Drugmaker Akorn Have A Healthy Bounce Up?

11:09 a.m. Sept. 18, 2014
- Investors Business Daily

Stocks with Upgraded Broker Ratings - Screen of the Week

3:57 a.m. Sept. 16, 2014
- Zacks.com

AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog

5:05 p.m. Sept. 12, 2014
- Zacks.com

5 Top Stocks With Rising Earnings Estimates

7:02 a.m. Sept. 12, 2014
- Investors Business Daily

Wall Street Breakfast: EU Places New Sanctions On Russia, U.S. To Follow

6:32 a.m. Sept. 12, 2014
- Seeking Alpha

Akorn In Second Test Of 10-Week Line

5:09 p.m. Sept. 11, 2014
- Investors Business Daily

Akorn reportedly eyeing tax inversion deal

4:07 p.m. Sept. 11, 2014
- Seeking Alpha

Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog

4:45 p.m. Sept. 10, 2014
- Zacks.com

10 Stocks with 5-Year Returns of 1,500%-Plus

5:10 a.m. Sept. 10, 2014
- InvestorPlace.com

Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog

5:20 p.m. Sept. 8, 2014
- Zacks.com

Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog

5:05 p.m. Sept. 5, 2014
- Zacks.com

Salix, Gilead Among 5 Top Medical Leaders To Watch

4:06 p.m. Sept. 5, 2014
- Investors Business Daily

Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog

4:30 p.m. Sept. 4, 2014
- Zacks.com

Will This Price Target Increase Help Akorn (AKRX) Stock Today?

9:27 a.m. Sept. 4, 2014
- TheStreet.com

Akorn (AKRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

8:54 a.m. Sept. 3, 2014
- Zacks.com

Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma
9:25 a.m. Sept. 8, 2014
- PR Newswire - PRF

Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn
8:30 a.m. Sept. 5, 2014
- PR Newswire - PRF

Akorn Completes Acquisition of VersaPharm
8:51 a.m. Aug. 12, 2014
- GlobeNewswire

Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed
9:20 a.m. Aug. 7, 2014
- PR Newswire - PRF

Akorn Reports Preliminary 2014 Second Quarter Results
6:05 a.m. Aug. 5, 2014
- GlobeNewswire

Global Parkinson%s Disease Market 2014-2018
6:42 p.m. July 28, 2014
- PR Newswire - PRF

Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
11:34 a.m. July 15, 2014
- GlobeNewswire

Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt
6:50 a.m. July 2, 2014
- PR Newswire - PRF

Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics
6:40 a.m. June 27, 2014
- PR Newswire - PRF

Akorn Divests ECR Pharmaceuticals to Valeant
11:11 a.m. June 20, 2014
- BusinessWire - BZX

Aerie Pharmaceuticals Names Craig R. Skenes as Vice President,
Business Development
4:05 p.m. June 16, 2014
- BusinessWire - BZX

Pharma Stocks Review -- Research on Akorn, Questcor Pharma, Nektar Therapeutics, and Endocyte
8:00 a.m. June 5, 2014
- PR Newswire - PRF

Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
7:20 a.m. May 16, 2014
- PR Newswire - PRF

Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn
11:30 a.m. May 9, 2014
- PR Newswire - PRF

Akorn to Acquire VersaPharm for $440 Million
9:19 a.m. May 9, 2014
- BusinessWire - BZX

Akorn Reports 2014 First Quarter Results
7:03 a.m. May 6, 2014
- BusinessWire - BZX

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF

Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF

Akorn Completes Acquisition of Hi-Tech Pharmacal
9:21 a.m. April 17, 2014
- BusinessWire - BZX

Repligen Corporation Set to Join the S&P SmallCap 600
5:53 p.m. April 15, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yas Island's Bold Move: Expanding With Potter Magic

Potter Magic Takes Over Warner Bros. World Abu Dhabi Call it a stroke of wizardry or plain savvy business sense, Miral and Warner Bros. Discovery Global Experiences are betting large on Harry Potter with a trio of themed lands at Warner Bros. World Abu Dhabi. Brace yourselves, because this ain't your mother's theme park nostalgia—this is about breathing new life into a...

GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Coastal Property Realities: A Deep Dive into Ownership

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

NeuralTrust Expands to London as AI Risks Intensify

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Overpricing in Atlanta Luxury Real Estate: Risks & Rewards

When Pricing Sends the Wrong Message Jump into the high stakes poker game of Atlanta's luxury real estate, and you'll find that pricing strategy is your make-or-break move. Jud Whitlock, a seasoned veteran over at Atlanta Fine Homes/Sotheby's International Realty, lays it all down: in this digital age, pricing too high is akin to waving a red flag at savvy buyers armed...

AI and Workforce Transformation: Zellis Connect 2026

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Automotive ECU Market Aims $160B by 2033

Automotive ECUs Under the Spotlight Picture this: By 2033, the automotive ECU market is expected to balloon to a whopping $160.59 billion. That's some serious cash, and it ain't just pocket change. This $47 billion jump from 2026 isn't just happening by accident—it's got everything to do with high-octane changes in the industry. With a 5.1% CAGR, you best believe it's a...

Advenica: Rising Star in Secure File Transfer Market

Advenica's Ascent in Secure File Transfer The cybersecurity world never sleeps, and with the rapid pace of digital threats, it's no surprise that secure file transfer solutions are becoming hotter commodities than coffee pots on Wall Street. Advenica, a name that might not ring a bell for everyone, has emerged as an 'Emerging Leader' in MarketsandMarkets' latest...

Jixingfeng Advances Smart Manufacturing for Socks Market

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...